Dissertation > Excellent graduate degree dissertation topics show

Vascular Endothelial Growth Factor (VEGF) in Congenital Heart Disease with Pulmonary Hypertension

Author: WangLiChun
Tutor: LvChaoXia
School: Dalian Medical University
Course: Internal Medicine
Keywords: Vascular endothelial growth factor Congenital heart disease Pulmonary hypertension
CLC: R541.1
Type: Master's thesis
Year: 2010
Downloads: 76
Quote: 0
Read: Download Dissertation


Objective: line involved in the detection of different time periods before and after treatment of vascular endothelial growth factor (VEGF) in patients with congenital heart disease, congenital heart disease and pulmonary hypertension (PH) patients involved in the changes before and after treatment serum levels of VEGF and the VEGF PH formation and development of the relationship. Methods: successful line congenital heart disease interventional transcatheter therapy of 50 patients with atrial septal defect (ASD) 22 cases, ventricular septal defect (VSD) 11 cases, patent ductus arteriosus (PDA) 17 cases, including 24 males and female 26 cases. Age 9-54 (31.6 ± 11.58) years of age. Patients without intravenous anesthesia, hypertension, diabetes and heart failure, no liver and kidney dysfunction, cancer and other diseases, non-pregnancy and lactation. Surgery, right heart catheterization in patients with congenital heart disease, directly measured pulmonary pressures, superior vena cava, the inferior vena cava, right atrium, right ventricle, pulmonary artery and the femoral artery or left atrial blood gas analysis, calculation points traffic. Normal pulmonary artery pressure group (mPAP ≤ 25mmHg) 18 cases, mild pulmonary hypertension group (25 lt; mPAP ≤ 35mmHg) 20 patients with moderate to severe pulmonary hypertension group (mPAP gt; 35mmHg) 12. Three age groups and gender difference was not statistically significant (P gt; 0.05). Confirmed that the health of the normal control group (15 males and 27 cases of examination centers; 12 females), aged 21-53 (29.0 ± 9.7) years old. Patients before the intervention, after 1 hour, blood samples after 24 hours and 30 days after surgery. The blood samples were extracted outer peripheral blood 2ml, serum separation tube for collecting blood samples, agglutination immediately centrifuged after 30 minutes (1000g x 15 minutes) and serum was separated. Blood serum in Eppendorf tubes, placed in a -70 ° C freezer refrigerators to be tested, measured using a double antibody sandwich ABC-ELISA method of vascular endothelial growth factor. Kit on Haixi Tang biotechnology company. Statistical Methods: spss for windows 17 statistical software analysis and processing, experimental All data are expressed as mean ± standard deviation (x ± s). Between the case and control groups and between the same group using t test among the three groups and the control group difference was significant using analysis of variance, P lt; 0.05 indicated significant difference. VEGF levels and pulmonary artery pressure, left to right shunt flow intercropping statistical analysis. Results: normal pulmonary artery pressure groups (105.06 ± 56.060pg/ml) with the control group (75.90 ± 52.833pg/ml) significant difference (P gt; 0.05); pulmonary hypertension group than in the control group were statistically differences, namely light the degree of pulmonary hypertension group (134.32 ± 57.82pg/ml) higher than that of the control group (75.90 ± 52.833pg/ml) was statistically significant (P lt; 0.05), and significantly higher in severe pulmonary hypertension group (193.36 ± 61.51pg/ml) in the control group (75.90 ± 52.83pg/ml) was statistically significant (P lt; 0.01); intervene in one hour and 24 hours after closure was no significant difference (P gt; 0.05), 30 days after plugging surgery before significant difference (P lt; 0.01); correlation analysis showed that serum VEGF levels with congenital heart left to right shunt flow was positively correlated with pulmonary artery pressure was positively correlated. Conclusion: CHD patients with left-to-right shunt, the of VEGF measured values ??and PH level was positively correlated, suggesting that VEGF plays an important role of mediated process caused by congenital heart disease, pulmonary vascular remodeling PH. 2.CHD patients with left-to-right points the greater the flow, the more obvious VEGF levels increased, increased pulmonary blood flow is an important factor to cause PH. 24 hours after VEGF by 3.CHD closure began to decline, particularly evident a month later, VEGF reversible congenital cardiac interventional therapy can effectively improve the PH, pulmonary artery pressure recovery may take longer.

Related Dissertations

  1. The Expression of MMP-2、 VEGF and Ki-67 and Human Glioma Grade,R739.41
  2. The Research on Treatment of Lentivirus-mediated hVEGF-165 Gene Transferring Mesenchymal Stem Cells on Rat Hind Limb Ischemia,R329
  3. BMP2 and VEGF165 Genes Transfected Rat Bone Marrow Mesechymal Stem Cells Simultaneity Expression,R329
  4. Expression of TNF-α, MMP-9 and VEGF in BALF of Rats with Emphysema and Their Mutual Relationship,R563.3
  5. Right armpit straight incision surgery for congenital heart disease,R654.2
  6. Influence and Significance of MMP-2 and VEGF of Hemangioma Endothelial Cells in Vitro Culture by Propranolol,R739.5
  7. The Investigation of Relationship between Therapeutic Effect and Prognosis and Changes of Peripheral Blood Vascular Endothelial Growth Factor and Metallothionein in Patients with Advanced Lung Cancer,R734.2
  8. Study on the Correlation btween Serum, Aqueous Humor VEGF, IL-6 Levels and the Neovascular Glaucoma,R775
  9. The Analysis of the Growth Factor Related with the Secondary Glaucoma in the Anterior Champer of Silicone Oil-filled Eyes,R779.6
  10. Vascular endothelial growth factor on endothelial cells concentration of magnesium ions,R965
  11. Experimental Studies on Therapy of Lung Cancer by VEGF-C siRNA Mediated by Liposomes,R734.2
  12. Meningiomas and MMP-9, VEGF expression and tumor angiogenesis and recurrence,R739.45
  13. Vascular Endothelial Growth Factor Gene Transfection Bone Marrow Stromal Cells Establish Scaffold to Treat the Ischemic Necrosis of Lunate Bone of Dogs,S858.292
  14. Experimental Study of the Relationship between Pulmonary Metastasis in Osteosarcomas and Vascular Endothelial Growth Factor Expression and Microvessel Density,R738.1
  15. The Effect of IL-17 on VEGF Expression in Human Nsclc Cell in Vitro,R734.2
  16. Propranolol for Haemangiomas-insight into VEGF/ERK Signaling Transduction in HUVEC-12 Cells,R965
  17. The Mechanism of Triamcinolone Acetonide in Inhibiting Retinal Neovascularizations in Oxygen-Induced Retinopathy Models,R774.1
  18. Effect of Candesartan on Expression of VEGF and MCP-1 in Rat Retina with Diabetetes Mellitus,R774.1
  19. Correlation between CT Perfusion Imaging in Nonsmall-cell Lung Cancer and VEGF、MVD、VEGF-C、LVD,R734.2
  20. Expression of Survivin、FHIT、VEGF-C in Gastric Adenocarcinoma and the Correlation Among the Three Factors,R735.2
  21. Relaionship among Expression of ESM-1, VEGF-D, Lymphangiogenesis and Lymph Node Metastasis in Human Invasive Lobular Breast Cancer,R737.9

CLC: > Medicine, health > Internal Medicine > Heart, blood vessels ( circulatory ) disease > Heart disease > Congenital heart disease
© 2012 www.DissertationTopic.Net  Mobile